CAPTRUST Financial Advisors
CDAK

CAPTRUST Financial Advisors’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-142
Closed – – 4476
2022
Q2 		$0 Hold
142
– – ﹤0.01% 5244
2022
Q1 		$1K Hold
142
– – ﹤0.01% 4799
2021
Q4 		$2K Hold
142
– – ﹤0.01% 4477
2021
Q3 		$2K Buy
+142
New +$2.54K ﹤0.01% 4326

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CAPTRUST Financial Advisors's CDAK Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2022, closing a stake of 142 shares.

CAPTRUST Financial Advisors first reported a position in CDAK in Q3 2021 and held it in 4 quarters. The position peaked at $2K in Q4 2021. 48 funds tracked by Wall St. Rank hold CDAK as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 142 Codiak BioSciences, Inc. Common Stock shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Codiak BioSciences, Inc. Common Stock position peaked at $2K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.